Clinical trial
Glycine vs Placebo for the Schizophrenia Prodrome
NCT00291226 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glycine vs Placebo for the Schizophrenia Prodrome
- Lead sponsor
- Yale University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 31, 2006
- Completion date
- July 31, 2009
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schizophrenia prodrome